Dr. Paul David Dash, MD

Dr. Dash practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Dash's NPI, 1942237987, was assigned on June 26, 2006. Dr. Dash graduated from University of California, Irvine, California College of Medicine in 1984. Dr. Dash holds Maryland license D63817.

Dr. Dash's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Dash's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. The medical group on file is University of Maryland Neurology Associates, P.A. Dmand AI also links Dr. Dash to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dash practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Dash's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Dash is licensed in Maryland.

CMS data shows 198 Medicare services from Dr. Dash across 3 procedure codes in 2024, all of them office visits, for 165 Medicare patients. Medicare paid $18,258 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 165 Medicare patients who saw Dr. Dash in 2024. The largest group is 65 to 74, with 64 patients. 73% of them have high blood pressure, and 73% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dash's median patient age at 58, with 77% women.

In 2024, Dr. Dash wrote 1,105 Medicare Part D claims for 167 patients. 77% of them were for generic drugs. CMS names the drug for 880 of them, across 25 drugs with 11 or more claims each, at $279,116 in total drug cost. In 2023, CMS named 722 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Dash for performance year 2024, reported as part of a group.

Dmand AI links 6 papers to Dr. Dash, published from 2015 to 2023. 2015 was the busiest year, with 2. The most frequent topics are Migraine Disorders, Double-Blind Method and Sumatriptan. Dr. Dash has published most often in Headache. Dr. Dash's most frequent co-authors are Barbara Lee Peterlin, DO, Gretchen E. Tietjen, MD and Muhammad Haroon Burhanullah, MD.

CMS Open Payments shows 492 general payments to Dr. Dash from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $32,202.

Dr. Dash graduated from University of California, Irvine, California College of Medicine in 1984.